EP3705144B1 - Récipient de solution de dialyse. - Google Patents

Récipient de solution de dialyse. Download PDF

Info

Publication number
EP3705144B1
EP3705144B1 EP18896378.9A EP18896378A EP3705144B1 EP 3705144 B1 EP3705144 B1 EP 3705144B1 EP 18896378 A EP18896378 A EP 18896378A EP 3705144 B1 EP3705144 B1 EP 3705144B1
Authority
EP
European Patent Office
Prior art keywords
bag body
interior
dialysate solution
pharmaceutical agent
filter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP18896378.9A
Other languages
German (de)
English (en)
Other versions
EP3705144A1 (fr
EP3705144A4 (fr
Inventor
Hiroshi Nimura
Masato Fujiwara
Takayoshi Yokoyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nikkiso Co Ltd
Original Assignee
Nikkiso Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nikkiso Co Ltd filed Critical Nikkiso Co Ltd
Publication of EP3705144A1 publication Critical patent/EP3705144A1/fr
Publication of EP3705144A4 publication Critical patent/EP3705144A4/fr
Application granted granted Critical
Publication of EP3705144B1 publication Critical patent/EP3705144B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654—Dialysates therefor
    • A61M1/1656—Apparatus for preparing dialysates
    • A61M1/1668—Details of containers
    • A61M1/167—Flexible packaging for solid concentrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654—Dialysates therefor
    • A61M1/1656—Apparatus for preparing dialysates
    • A61M1/1666—Apparatus for preparing dialysates by dissolving solids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654—Dialysates therefor
    • A61M1/1656—Apparatus for preparing dialysates
    • A61M1/1672—Apparatus for preparing dialysates using membrane filters, e.g. for sterilising the dialysate

Definitions

  • the first bag body 10 surrounds the second bag body 20. Thereby, the dialysate solution W that flows out from the second interior of the second bag body 20 through the first filter 22 of the second bag body 20 can be stored in the first interior of the first bag body 10.
  • the first bag body 10 may surround the second bag body 20 and the third bag body 30. Thereby, a solution, in which the first powdered pharmaceutical agent 1 is dissolved, may flow out through the first filter 22 to the third interior of the third bag body 30 where the second powdered pharmaceutical agent 2 is dissolved to produce the dialysate solution W, and then the dialysate solution W may be stored in the first interior of the first bag body 10.
  • the shape of the first filter 22 is not limited to a three dimensional shape which is convex in the upward direction, and the first filter 22 may be of any shape that divides the flow of the jetted water RO into multiple directions of up, down, left, and right.
  • the dialysate container 100A according to the second embodiment differs from the dialysate container 100 according to the first embodiment described above mainly in the points that that the first bag body 10 is replaced with the first bag body 10A, and the second bag body 20 and the third bag body 30 are provided at the exterior of the first bag body 10A.
  • components which are the same as the components which were described above in the first embodiment may be denoted by the same reference numerals and descriptions thereof may be omitted.
  • the first bag body 10A is flexible in a manner similar to that of the first bag body 10 of the first embodiment described above, it can be folded in any manner.
  • the first bag body 10A can be folded back and folded at the positions indicated by the double dotted chain lines Z in FIG. 7 and be made into a compact shape. Therefore, the dialysis solution container 100A exhibits superior portability, is not bulky when transported or stored, and.is capable of saving space.
  • An upper end of a first connection pipe 50 is connected to the lower portion of the buffer chamber 40.
  • the lower side portion of the buffer chamber 40 is integrated (sealed) in a watertight manner by an appropriate means such as by being fused except for a location at which the first connection pipe 50 passes through.
  • a joint portion which is capable of connecting with the upper end of the first connection pipe 50 may be integrated with the lower portion of the buffer chamber 40 instead of the upper end of the first connection pipe 50.
  • the upper end 61 of the second connection pipe 60 is connected to the first connection pipe 50, and the lower end opens into the first interior of the first bag body 10A. It is preferable for the lower end of the second connection pipe 60 to be located in the vicinity of the bottom portion of the first interior of the first bag body 10A. In this case, it is possible for substantially all of the dialysate solution W (the produced dialysate W) which is formed in the first interior of the first bag body 10A to be discharged to the dialysis circuit at the exterior of the first bag body 10A via the transferred to the second connection pipe 60, the first connection pipe 50, the third bag body 30, the second bag 20, and the communication pipe 21. That is, the utilization efficiency of the produced dialysate W can be improved.
  • the flexible second bag body 20 and the flexible third bag body 30 are utilized.
  • the present disclosure is not limited to such a configuration.
  • the second bag body 20 and/or the third bag body 30 may be partially or entirely inflexible.
  • the second bag body 20 and the third bag body 30 may be formed by resin.
  • the portion which is formed by the resin and the portions which are formed by the flexible material may be coupled by being fused, etc.

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • External Artificial Organs (AREA)

Claims (10)

  1. Récipient (100, 100A) de solution de dialysat comprenant :
    un premier corps de sac flexible (10, 10A) ayant un premier intérieur,
    un premier agent pharmaceutique en poudre (1), et
    un deuxième corps de sac flexible (20) ayant un deuxième intérieur, le deuxième corps de sac (20) contenant de façon scellée le premier agent pharmaceutique en poudre (1) ;
    le deuxième corps de sac (20) comprenant
    une zone de mélange (M) dans la partie d'extrémité inférieure du deuxième intérieur,
    le premier agent pharmaceutique en poudre (1) étant apte à être mélangé avec de l'eau (RO) dans ladite zone de mélange (M) ; et
    un tuyau de communication (21) par lequel l'extérieur du deuxième corps de sac (20) est en communication avec le deuxième intérieur et une première extrémité (21a) du tuyau de communication (21) étant apte à être connectée à un circuit de dialyse, et la deuxième extrémité (21b) du tuyau de communication (21) étant disposée dans ladite zone de mélange (M) ;
    caractérisé en ce que le deuxième corps de sac (20) comprend
    un premier filtre (22) par lequel le deuxième intérieur est en communication avec le premier intérieur du premier corps de sac (10, 10A).
  2. Récipient (100, 100A) de solution de dialysat comprenant :
    un premier corps de sac flexible (10, 10A) ayant un premier intérieur,
    un premier agent pharmaceutique en poudre (1), et
    un deuxième corps de sac (20) ayant un deuxième intérieur, au moins une partie du deuxième corps de sac (20) étant formée par un matériau inflexible ;
    le deuxième corps de sac (20) contenant de façon scellée le premier agent pharmaceutique en poudre (1) et comprenant :
    une zone de mélange (M) dans la partie d'extrémité inférieure du deuxième intérieur,
    le premier agent pharmaceutique en poudre (1) étant apte à être mélangé avec de l'eau (RO) dans ladite zone de mélange (M) ; et
    un tuyau de communication (21) par lequel l'extérieur du deuxième corps de sac (20) est en communication avec le deuxième intérieur, une première extrémité (21a) du tuyau de communication (21) étant apte à être connectée à un circuit de dialyse, et la deuxième extrémité (21b) du tuyau de communication (21) étant disposée dans ladite zone de mélange (M) ;
    caractérisé en ce que le deuxième corps de sac (20) comprend
    un premier filtre (22) par lequel le deuxième intérieur est en communication avec un premier intérieur du premier corps de sac (10, 10A).
  3. Récipient (100, 100A) de solution de dialysat selon la revendication 1 ou la revendication 2, dans lequel
    le tuyau de communication (21) qui est compris dans le deuxième corps de sac (20) est un tuyau de communication (21) seul qui est compris dans le récipient (100, 100A) de solution de dialysat par lequel de l'eau (RO) peut être injecté dans le récipient (100, 100A) de solution de dialysat.
  4. Récipient (100, 100A) de solution de dialysat selon l'une quelconque des revendications 1 à 3, dans lequel
    le deuxième corps de sac (20) comprend, dans une partie d'extrémité inférieure du deuxième intérieur, une partie étroite qui restreint l'espace dans le deuxième intérieur de façon que l'extrémité inférieure de la partie étroite est adjacente à une partie de diamètre extérieur maximum du premier filtre (22).
  5. Récipient (100, 100A) de solution de dialysat selon l'une quelconque des revendications 1 à 4, dans lequel
    le tuyau de communication (21) est disposé de façon qu'une ouverture de buse la deuxième extrémité (21b) de celui-ci fait face au premier filtre (22).
  6. Récipient (100, 100A) de solution de dialysat selon l'une quelconque des revendications 1 à 5, dans lequel
    le premier filtre (22) comprend une partie supérieure et une surface courbée en trois dimensions qui est convexe en direction vers le haut.
  7. Récipient (100, 100A) de solution de dialysat selon l'une quelconque des revendications 1 à 6, comprenant en outre :
    un troisième corps de sac flexible (30) ayant un troisième intérieur, le troisième corps de sac (30) comprenant un deuxième agent pharmaceutique en poudre (2),
    le troisième corps de sac (30) comprenant un deuxième filtre (31) qui est en communication avec le premier corps de sac (10, 10A), et
    le troisième corps de sac (30) étant disposé de façon que le troisième intérieur du troisième corps de sac (30) est en communication avec le deuxième intérieur du deuxième corps de sac (20) via le premier filtre (22), et le troisième intérieur du troisième corps de sac (30) est en communication avec le premier intérieur du premier corps de sac (10, 10A) via le deuxième filtre (31).
  8. Récipient (100) de solution de dialysat selon la revendication 7, dans lequel
    le premier corps de sac (10) enveloppe le deuxième corps de sac (20) et le troisième corps de sac (30).
  9. Récipient (100) de solution de dialysat selon l'une quelconque des revendications 1 à 8, dans lequel
    le premier corps de sac (10) enveloppe le deuxième corps de sac (20).
  10. Récipient (100A) de solution de dialysat selon l'une quelconque des revendications 1 à 8, dans lequel
    le deuxième corps de sac (20) est prévu à l'extérieur du premier corps de sac (10A) ; et
    le récipient (100A) de solution de dialysat comprend en outre un tuyau de connexion dont une première extrémité est dans le premier intérieur du premier corps de sac (10A) et une deuxième extrémité est en communication avec le premier filtre (22).
EP18896378.9A 2017-12-26 2018-12-11 Récipient de solution de dialyse. Active EP3705144B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017249135 2017-12-26
PCT/JP2018/045549 WO2019131119A1 (fr) 2017-12-26 2018-12-11 Récipient de fluide de dialyse

Publications (3)

Publication Number Publication Date
EP3705144A1 EP3705144A1 (fr) 2020-09-09
EP3705144A4 EP3705144A4 (fr) 2021-07-07
EP3705144B1 true EP3705144B1 (fr) 2023-09-27

Family

ID=67063527

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18896378.9A Active EP3705144B1 (fr) 2017-12-26 2018-12-11 Récipient de solution de dialyse.

Country Status (5)

Country Link
US (1) US11446418B2 (fr)
EP (1) EP3705144B1 (fr)
JP (1) JP7200135B2 (fr)
CN (1) CN111511417B (fr)
WO (1) WO2019131119A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023085999A1 (fr) * 2021-11-09 2023-05-19 Staymed Ab Dispositif et système fournissant une solution médicale et procédé associé

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0636813B2 (ja) * 1992-04-17 1994-05-18 大研医器株式会社 体液を含む廃液の処理方法および処理容器
JP2002537916A (ja) 1999-03-03 2002-11-12 プリスメディカル コーポレーション 血液透析溶液を製造するための方法及び装置
US20040211718A1 (en) * 2000-02-16 2004-10-28 Tsuneo Deguchi Apparatus for preparing a dialyzate and a powder dialysis preparation
EP3165252B1 (fr) * 2002-03-11 2021-04-07 Fresenius Medical Care Deutschland GmbH Connecteur, récipient avec tel connecteur et dispositif de préparation de liquide avec connecteur correspondant à un tel récipient
JP4178109B2 (ja) 2002-07-16 2008-11-12 フレゼニウス メディカル ケアー ドイチュラント ゲゼルシャフト ミット ベシュレンクテル ハフツング 透析用容器
SE526154C2 (sv) * 2003-04-07 2005-07-19 Gambro Lundia Ab Filter för patron innehållande ett partikelformigt material, patron innehållande ett partikelformigt material, användning av filter för sådan patron samt system för framställning av en flytande lösning för ett medicinskt förfarande innehållande sådant filter och sådan patron
GB2422794B (en) * 2005-02-05 2009-04-22 Diasys Europ Ltd Filtration device for biological samples
JP5202005B2 (ja) * 2008-01-22 2013-06-05 テルモ株式会社 液体回収バッグおよび体外循環回路
DE102009058445B4 (de) 2009-12-16 2016-09-15 Fresenius Medical Care Deutschland Gmbh Mehrkammer-Beutel
DE102011017048A1 (de) * 2011-04-14 2012-10-18 Fresenius Medical Care Deutschland Gmbh Mehrkammercontainer zur Herstellung medizinischer Lösungen
DE102011106248A1 (de) * 2011-07-01 2013-01-03 Fresenius Medical Care Deutschland Gmbh Behälter, Verwendung, Dialysegerät oder Zubereitungseinheit sowie Verfahren zur Herstellung eines Konzentrats
WO2013022163A1 (fr) 2011-08-10 2013-02-14 Lee Choong-Joong Buse venturi et structure de filtration équipée de celle-ci pour dispositif de dépoussiérage
FR2978914B1 (fr) * 2011-08-11 2013-08-16 Fresenius Medical Care De Gmbh Recipient pour dialyse
EP2905039A1 (fr) 2014-02-07 2015-08-12 Fresenius Medical Care Deutschland GmbH Concentré d'acide sec sous forme de granulés
CN205515730U (zh) * 2015-12-15 2016-08-31 天津泰士康制药科技有限公司 一种新型血液干粉透析袋

Also Published As

Publication number Publication date
CN111511417A (zh) 2020-08-07
US20200324036A1 (en) 2020-10-15
WO2019131119A1 (fr) 2019-07-04
JP7200135B2 (ja) 2023-01-06
CN111511417B (zh) 2023-04-14
US11446418B2 (en) 2022-09-20
EP3705144A1 (fr) 2020-09-09
JPWO2019131119A1 (ja) 2020-12-17
EP3705144A4 (fr) 2021-07-07

Similar Documents

Publication Publication Date Title
CN102378726B (zh) 使用时混合容器及其使用方法
CN100441160C (zh) 医用多室容器
CN101437483B (zh) 带防误操作给药系统的多腔容器
KR100964999B1 (ko) 유체물의 저장 및 배출용 장치
US4871354A (en) Wet-dry bag with lyphozation vial
US9993784B2 (en) Device for preparing a solution, in particular in or on a dialysis machine
EP0333075B1 (fr) Récipient pour produit de traitement
CN103458749A (zh) 两种材料的囊状件
CN102413717A (zh) 用于制备营养产品的包括过滤器的胶囊和方法
KR20000064786A (ko) 자동 프라이밍 용액 라인 및 그 이용 방법 및시스템
CN103209727A (zh) 用于储藏医学或药学液体的容器
KR101876186B1 (ko) 액체기체 동시분사형 농약교반과 양수 고속공급의 일체형 교반 및 양수장치
EP3705144B1 (fr) Récipient de solution de dialyse.
CN112020345A (zh) 提供用于肠外营养物的制剂的设备和方法
KR20110058868A (ko) 주출구 및 주출구가 달린 액체 수용체
US20050096625A1 (en) Welding shuttle for a bag
JP6534353B2 (ja) 注出容器
KR100448954B1 (ko) 일체의라인세트를구비한비경구적유체송출백
CN112399863A (zh) 柔性容器系统和管嘴以及相关方法
JPH07204480A (ja) 薬剤注入装置
US11793722B2 (en) Valve unit for a system for producing a medical preparation
JP2019026348A (ja) 二重容器
JP2011103953A (ja) 医療用複室容器
CN112020344A (zh) 用于混合系统的容器、用于肠外营养物的混合系统以及混合方法
JP4609791B2 (ja) 複室容器

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20200605

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20210608

RIC1 Information provided on ipc code assigned before grant

Ipc: A61M 1/16 20060101AFI20210601BHEP

Ipc: A61J 1/10 20060101ALI20210601BHEP

Ipc: A61J 1/14 20060101ALI20210601BHEP

Ipc: A61J 1/20 20060101ALI20210601BHEP

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20230420

RIN1 Information on inventor provided before grant (corrected)

Inventor name: YOKOYAMA, TAKAYOSHI

Inventor name: FUJIWARA, MASATO

Inventor name: NIMURA, HIROSHI

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230523

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602018058461

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG9D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231228

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20231220

Year of fee payment: 6

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230927

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230927

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231227

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230927

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230927

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230927

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231228

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230927

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20231222

Year of fee payment: 6

Ref country code: DE

Payment date: 20231214

Year of fee payment: 6

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20230927

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1614767

Country of ref document: AT

Kind code of ref document: T

Effective date: 20230927

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230927

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240127

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230927

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230927

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230927

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230927

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240127

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230927

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230927

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230927

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230927

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230927

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240129

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230927

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230927

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602018058461

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230927

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230927

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20231211

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230927

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20231231

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230927

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20231211

26N No opposition filed

Effective date: 20240628

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20231211

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20231231